Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Biolase Technology, Inc.
(NQ:
BIOL
)
4.770
USD
-0.170 (-3.44%)
Streaming Delayed Price
/ Updated:
10:10 AM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Biolase Technology, Inc.
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
BIOLASE Declares Stock Dividend for 2013 Second Quarter
May 21, 2013
from
Marketwired News Releases
NewTom BIOLASE VG3 Panoramic Oral X-Ray System Receives FDA Clearance
May 16, 2013
VG3 Expected to Be Available for Delivery in June 2013
Read More
from
Marketwired News Releases
BIOLASE Awarded Two New Patents
May 15, 2013
For Laser Delivery Systems for Tooth Whitening, Pain Therapy and Medical Applications; For Various Configurations of Battery Operated Lasers With Wireless Transmitters
Read More
from
Marketwired News Releases
BIOLASE Receives FDA Clearance for Orthopedic and Podiatric WaterLase iPlus
May 08, 2013
First Non-Dental Clearance for the Flagship WaterLase iPlus
Read More
from
Marketwired News Releases
BIOLASE Enters Affiliation Agreement With Sun Dental Laboratories, LLC
May 07, 2013
Strategic Partnership to Leverage Sun Dental Labs' Significant Customer Base as Market for BIOLASE to Sell Trios Intraoral Scanners
Read More
from
Marketwired News Releases
USPTO Rejects All Claims Subject to Reexamination in the CAO Group's Patent Action Against BIOLASE
May 07, 2013
from
Marketwired News Releases
Comerica Increases Available Borrowings Under Amended Credit Facilities
May 07, 2013
Includes Reduction of Interest Rates; Establishment of Certain Financial and Non-financial Covenants; and $1 Million of Additional Mid-Quarter Borrowing Capacity
Read More
from
Marketwired News Releases
BIOLASE Reports 2013 First Quarter Results
May 07, 2013
Net Revenue Increases 19% to $14.6 Million, Quarter Over Quarter; Laser System Revenue Increases 9%, Quarter Over Quarter; Imaging Revenue Increases 619%, Quarter Over Quarter; 2013 Annual Revenue...
Read More
from
Marketwired News Releases
Wall Street Journal Article Features BIOLASE's Virtually Painless WaterLase Technology
May 01, 2013
BIOLASE's Alternative WaterLase Technology Increases Patient Comfort by Avoiding Painful Injections of Anesthesia When Compared to Conventional Dentistry and the Dental Drill
Read More
from
Marketwired News Releases
BIOLASE to Host First Quarter 2013 Results Conference Call and Webcast on May 7th at 4:30 P.M. EDT
April 30, 2013
from
Marketwired News Releases
BIOLASE Enters Into Agreement for Lambda S.p.A. to Pay Royalties
April 17, 2013
Agreement Resulted in a Payment From Lambda for Past Royalties and Established Royalty Rate for Future Payments
Read More
from
Marketwired News Releases
BIOLASE Awarded New Patent for Non-Contact Handpiece for Tissue Cutting
April 16, 2013
from
Marketwired News Releases
Hot Equities Review: (NASDAQ:DCTH), (NASDAQ:BIOL)
April 15, 2013
from
SBWire Direct - Latest Press Releases
Biolase Inc.&Galena Biopharma Inc. News and Reports: (NASDAQ: BIOL), (NASDAQ: GALE)
April 12, 2013
from
SBWire Direct - Latest Press Releases
Biolase Inc.&Galena Biopharma Inc. News and Reports: (NASDAQ:BIOL), (NASDAQ:GALE)
April 12, 2013
from
SBWire Direct - Latest Press Releases
Free Research Reports on BIOL, CLGX, CVX and ZUMZ Issued by the Paragon Report
April 12, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
Read More
from
Marketwired News Releases
BIOLASE Receives FDA Clearance for the EPIC 10S Soft Tissue Diode Laser for a Broad Spectrum of Medical Procedures
April 11, 2013
Clearance for Over 80 Procedures in 19 Additional Medical Markets
Read More
from
Marketwired News Releases
BIOLASE Engages Porter, LeVay & Rose, Inc. for Investor Relations
April 11, 2013
from
Marketwired News Releases
BIOLASE Joins OSAP in Fight for Safe and Infection-Free Oral Healthcare
April 04, 2013
from
Marketwired News Releases
BIOLASE Holds Annual Distributor Meeting at 35th IDS International Dental Show in Cologne, Germany
March 13, 2013
Awards Presented to Top Distributors
Read More
from
Marketwired News Releases
BIOLASE Reports 2012 Fourth Quarter, Year-End Results
March 06, 2013
Net Revenue Increases 45.0% to $19.1 Million, Quarter Over Quarter; Core WaterLase Unit Sales Increase 42.0%, Quarter Over Quarter; Net Income of $1.0 Million -- $0.03 per share -- in Q4 2012; Non-GAAP...
Read More
from
Marketwired News Releases
BIOLASE CEO to Continue at Symbolic Annual Cash Salary of $1.00
March 06, 2013
from
Marketwired News Releases
BIOLASE Declares Stock Dividend for 2013 First Quarter
February 28, 2013
Sets March 15, 2013 as Record Date; Board Approves a Two Percent Annual Stock Dividend Policy
Read More
from
Marketwired News Releases
BIOLASE Launches Soft-Tissue Diode Laser for Veterinary Applications
February 26, 2013
EPIC V-Series Boasts Numerous Special Features: Best Market Pricing; Easy-Installation, Fully-Portable and Lightweight; Patented EZ Tips(R) Technology for Dental and Surgical Procedures; Deep Tissue...
Read More
from
Marketwired News Releases
BIOLASE to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
February 14, 2013
from
Marketwired News Releases
BIOLASE to Host Fourth Quarter Financial Results Conference Call on March 6, 2013
February 13, 2013
from
Marketwired News Releases
BIOLASE Recognized With "Best AEEDC Dubai Booth Activities Award" at Recent UAE Dental Conference & Arab Dental Exhibition
February 12, 2013
from
Marketwired News Releases
Zynga, Inc. Fourth-Quarter Earnings and Sales Topped Wall Street Estimates
February 11, 2013
from
PR Newswire
BIOLASE Issued Broad New Patent for Treating Eye Conditions, Including Presbyopia, Cataracts, and Glaucoma
February 07, 2013
Provides Additional Support for Ophthalmic Applications
Read More
from
Marketwired News Releases
Free Research Reports on BIOL, EMKR, GDP and GME Issued by the Bedford Report
February 07, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here